Ecstasy slated for human trials in PTSD treatment

Via Discover, which provides a somewhat insensitively cheeky headline:

Post-traumatic stress disorder—PTSD—can linger years after someone has experienced or witnessed something extremely upsetting. It may be accompanied by panic attacks, flashbacks, and nightmares, and it can be fiendishly difficult to treat. But experimental types of treatment could soon lend a hand.

In a pilot study, South Carolina psychiatrist Michael Mithoefer is targeting PTSD with a controversial drug: methylenedioxymethamphetamine, or MDMA, commonly known as Ecstasy. He gave MDMA, along with psychotherapy, to 21 participants who had developed treatment-resistant PTSD as a result of experiences with crime or war. Only 15 percent of the MDMA-treated subjects continued to experience PTSD afterward, as opposed to 85 percent of the subjects who received psychotherapy with a placebo. Mithoefer considers the findings especially notable given that 20 of the 21 participants had previously failed to obtain relief from FDA-approved treatments. “The next step is to find out if this can be replicated elsewhere,” he says. The study, sponsored by the Multidisciplinary Association for Psychedelic Studies, was the first FDA-approved trial evaluating MDMA’s therapeutic applications. Additional clinical tests examining MDMA-based treatments for PTSD are under way in Switzerland and Israel.

Other potential PTSD drugs also show promise. Researchers at Mount Sinai School of Medicine in New York City report that one or two treatments with a compound called RU38486 can disrupt traumatic memories in rats without affecting normal memories. And investigators at Tel Aviv University and Ben-Gurion University in Israel find that an injection of the steroid cortisol immediately following a trauma reduces PTSD-like effects in mice. Both of these therapies are slated for human clinical trials.

Now, not to sensationalize this story–“E” has been used in studies to treat depression–but. When I took Psych. 101 [two? three?] years ago, we discussed psychoactive drugs. Ecstasy is still new enough that the literature on the drugs is rather slim, which is to say there is little that can be said about it with any degree of confidence . Though one appreciates what the researchers are trying to do, and recognizes the necessity of what they’re doing, one can’t help but feel squeamish about the prospect. But then, science would be nowhere if squeamishness could not be overcome.

All this is to say: I hope the Mount Sinai people know what they’re doing. Given that they’re at Mount Sinai, they probably do.

Advertisements

One Response

  1. The information presented is top notch. I’ve been doing some research on the topic and this post answered several questions.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: